Ryan Bloom

Ryan Bloom currently serves as Vice President and Head of Business Development at Superluminal Medicines Inc. since November 2024. Prior to this role, Ryan held various positions at BlueRock Therapeutics, culminating in Senior Director of Business Development, where responsibilities included business development and new product planning. At Unum Therapeutics, Ryan contributed to corporate development, focusing on business strategy and financing. Earlier experience includes serving as Program Leader for Immuno-Oncology at Cofactor Genomics, where Ryan directed product development and partnerships, and founding Narus Biotechnologies, overseeing corporate development and fundraising. Ryan's academic background includes a PhD in Bioengineering from Stanford University and a B.S. in Chemical and Biomolecular Engineering from The Johns Hopkins University.